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ABSTRACT
HIV testing is free in Malawi, but users may still incur costs that can deter or delay them accessing
these services. We sought to identify and quantify these costs among HIV testing service clients in
Malawi. We asked residents of communities participating in a cluster randomised trial investigating
the impact of HIV self-testing about their past HIV testing experiences and the direct non-medical
and indirect costs incurred to access HIV testing. We recruited 749 participants whose most recent
HIV test was within the past 12 months. The mean total cost to access testing was US$2.45 (95%CI:
US$2.11–US$2.70). Men incurred higher costs (US$3.81; 95%CI: US$2.91–US$4.50) than women (US
$1.83; 95%CI: US$1.61–US$2.00). Results from a two-part multivariable regression analysis suggest
that age, testing location, time taken to test, visiting a facility speciﬁcally for an HIV test and district
of residence signiﬁcantly aﬀected the odds of incurring costs to testing. In addition, gender, wealth,
age, education and district of residence were associated with signiﬁcant user costs.
Abbreviations: AIDS: Acquired Immune Deﬁciency Syndrome; ANC: Antenatal Care; ART:
AntiRetroviral Therapy; CBDA: Community-Based Distribution Agent; CBHTS: Community-Based
HIV Testing Services; CRT: Cluster Randomized trial; GLM: Generalised Linear Model; HIV: Human
Immunodeﬁciency Virus; HIVST: HIV Self-Testing; HTC: HIV Testing and Counselling; IHS:
Integrated Household Survey; OLS: Ordinary Least Squares; PCA: Principal Component Analysis;
PITC: Provider Initiated Testing and Counselling; PLHIV: People Living with HIV; STAR: Self-Testing
AfRica; TB: Tuberculosis; TPM: Two-Part Model; UNAIDS: The Joint United Nations Programme on
HIV/AIDS; VCT: Voluntary Counselling and Testing
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Introduction
Eastern and Southern Africa account for the highest
numbers of people living with HIV (PLHIV), newly
infected with HIV, and dying from HIV (UNAIDS,
2017). HIV testing is an essential gateway to HIV pre-
vention, treatment, care and support services since
receipt of an HIV diagnosis empowers individuals to
make informed decisions about follow on services in
the cascade (World Health Organization, 2015; World
Health Organization & UNAIDS, 2017). The global enti-
ties involved in AIDS eradication have adopted ambi-
tious treatment targets: by 2020, 90% of all PLHIV will
know their HIV status, 90% of all people with diagnosed
HIV infection will receive sustained antiretroviral
therapy (ART) and 90% of all people receiving ART
will have viral suppression (UNAIDS, 2014a). Ensuring
that 90% of PLHIV are aware of their status will support
enrolment in HIV care and achievement of these global
treatment goals (UNAIDS, 2014a).
However, despite impressive eﬀorts in scaling-up
availability of HIV testing and treatment services in the
region, including freely available HIV testing at nearly
all healthcare settings, testing uptake remains inadequate
to reach the global goals (Church et al., 2017). Malawi
has been leading the way in scaling-up HIV services
(Lowrance et al., 2008; UNAIDS, 2014b) but an esti-
mated 35% of men and 18% of women have never tested
for HIV and 60% of young people aged 15–19 years have
never tested (CDC & GoM, 2017). Uptake of HIV testing
also remains low amongst poorer individuals and those
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with less formal education (Kim, Skordis-Worrall, Hagh-
parast-Bidgoli, & Pulkki-Brännström, 2016).
Previous studies in sub-Saharan Africa have cited
location, distance, waiting time, costs, conﬁdentiality con-
cerns, low perceived risk and infrequent contact with the
health-care system as barriers to accessing HIV testing
(Angotti et al., 2009; Morin et al., 2006; Musheke et al.,
2013; Sharma, Ying, Tarr, & Barnabas, 2015). Individuals
often incur substantial access costs when utilising public
sector HIV testing and treatment services even when
they are provided free at point of use (Chimbindi et al.,
2015; Lubega et al., 2013; Maheswaran et al., 2016;
Pinto, Lettow, Rachlis, Chan, & Sodhi, 2013).
In urban settings, HIV testers incur costs close to
twice their daily earning incomes (Maheswaran et al.,
2016). These costs are likely to be higher in more rural
settings, however little is known about these costs and
whether these vary by diﬀerent population groups or
testing modalities, which limits eﬀorts to minimise or
oﬀset testing costs to increase uptake. Awareness of
costs incurred by rural HIV testers is particularly impor-
tant since 84% of the Malawi population is rural with
57% of the rural population classiﬁed as poor compared
to 17% of the urban population (International Monetary
Fund, 2017; World Bank, 2014). The poor in developing
countries like Malawi are even less likely than the better
oﬀ to receive eﬀective health care with existing costs
barriers proposed as one of the deterrents of this low
use (O’Donnell, 2007; Russel, 2004).
The World Health Organisation (WHO) guidelines
have highlighted the need for strategic approaches to
deliver HIV testing services (HTS) (World Health
Organisation, 2016). HIV self-testing (HIVST) and com-
munity-based HIV testing are proposed as having the
potential of increasing testing uptake especially for
men, key populations and young people who would
not normally access HIV testing services (Malawi Minis-
try of Health, 2016; World Health Organisation, 2016).
Young people for instance, have previously demon-
strated an aversion to price due to their limited access
to resources (Indravudh et al., 2017; Sibanda, Maringwa,
et al., 2017). Research on these costs is essential to appro-
priately targeting these sub-populations lagging behind
in access to testing.
In this study, we sought to examine (1) the costs
borne by users of HIV testing services in rural Malawi;
(2) whether certain population subgroups incur higher
costs; and (3) whether costs diﬀer based on the mode
of testing. To the best of our knowledge, this is the
ﬁrst study to identify and quantify speciﬁc costs of
HIV testing in a rural setting. Other studies in the
region have explored determinants of testing (Camlin
et al., 2016; Helleringer, Kohler, Frimpong, &
Mkandawire, 2009; Lépine, Terris-Prestholt, & Vicker-
man, 2014), costs of providing HIV services (Mahes-
waran et al., 2016; Mangenah, Mwenge, et al., 2017;
Mwenge et al., 2017; Sharma et al., 2015), and costs
of accessing tuberculosis (TB) treatment (Kemp,
Mann, Simwaka, Salaniponi, & Squire, 2007) and
ART (Bergmann, Wanyenze, & Stockman, 2017; Chim-
bindi et al., 2015; Pinto et al., 2013; Rosen, Ketlhapile,
Sanne, & DeSilva, 2007). The few that have explored
costs associated with HIV testing have either focused
on urban settings (Maheswaran et al., 2016) or exam-
ined costs without considering lost income (Bergmann
et al., 2017). The results of this study will inform the
design of future HIV testing services and interventions
aimed at overcoming ﬁnancial barriers to testing.
Methods
Study setting and design
HIV testing in Malawi is freely provided. Individuals
may voluntarily access HIV testing at a health facility;
may be advised to test by a health professional [provi-
der-initiated testing and counseling (PITC)]; may be
oﬀered testing as part of routine antenatal care (ANC)
(accessed by both the pregnant women and their accom-
panying male partners) or TB care (also a form of PITC);
or may have access to community-based HIV testing ser-
vices (CBHTS) including through testing campaigns and
outreach, home-based or door-to-door testing, work-
place testing, mobile testing, and testing through edu-
cational institutions.
We undertook a baseline household survey as part of a
cluster-randomised trial (CRT) investigating the impact
of community-based distribution of HIVST in rural
Malawi (ClinicalTrials.gov Identiﬁer: NCT02718274).
The CRT was conducted in rural villages of Blantyre,
Machinga, Mwanza and Neno in Southern Malawi.
The CRT comprised a population of approximately
62,500 residents with 22 clusters deﬁned by the service
catchment area of public primary health facilities with
active ART clinics. The HIV prevalence in the four dis-
tricts was approximately 11% (National Statistics Oﬃce
& ICF Macro, 2017).
Within each cluster, villages were selected for
inclusion in the baseline survey based on location,
population size, road accessibility and presence of
pre-existing reproductive health community-based dis-
tribution agents. Households in these evaluation vil-
lages were randomly sampled for a baseline
household survey which was conducted between May
and August 2016. The sampling of the survey ensured
inclusion of at least 250 adults per cluster, with the
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sample size calculated based on the primary outcome of
the trial. All household members aged 16 years or older
were eligible to participate in the survey. Details on the
sample size calculation for the main trial can be found
in the trial protocol available at http://hivstar.lshtm.ac.
uk/.
Research assistants visited selected households and
administered an electronic, face-to-face, questionnaire
to all household members aged above 16 years who
agreed to participate. The main questionnaire included
questions about sociodemographics and HIV testing his-
tory. Due to time and resource constraints, an extended
questionnaire was administered to a random 20% subset
of participants responding to the main questionnaire.
The extended questionnaire included questions on the
costs of HIV testing as well as other questions on health
care utilisation and stigma.
Assessing costs and location of HIV testing
Participants who reported testing within the previous 12
months were asked the location of testing, including
whether facility- or community-based; if their most
recent test was accessed separately from other health ser-
vices or as part of antenatal care ANC or PITC; total time
taken to access HIV testing; and the direct non-medical
and indirect costs they incurred. The 12 months recall
period is in line with other studies on health care use
and/or out-of-pocket expenditure (van Doorslaer &
Masseria, 2004; Heijink, Xu, Saksana, & Evans, 2011)
and a similar recall period is used to collect household
non-food expenditures in the Malawi integrated house-
hold survey which is a major socio-economic survey con-
ducted by the Malawi National Statistical Oﬃce. It is
worth noting that there is no general answer to the ques-
tion of optimal recall period with the choice dependent
on the primary objective of the data collection (Clarke,
Fiebig, & Gerdtham, 2008).
We derived a list of potential costs based on the litera-
ture and previous work undertaken in Malawi to inform
development of the study questionnaire (Kemp et al.,
2007; Maheswaran et al., 2016; Pinto et al., 2013). We
asked participants how much they had paid for the
round trip to the testing facility (transport cost), and if
they had paid any consultation or service fees (consul-
tation cost) related to testing (sometimes incurred at pri-
vate facilities), excluding any fees for other services they
accessed at the same time. Participants were also asked if
they spent money on any food and drink items (food
costs) while accessing testing and, if so, how much
they spent. Additionally, we asked participants about
any costs they might have incurred by paying a caretaker
to watch their children for the time they sought testing
(child care costs), and about any other costs they
might have incurred as they sought testing (other
costs). We further asked participants to approximate
the amount of money they would have earned during
the entire time they took to access testing (lost income).
Other covariates
Participants were also asked questions on socio-demo-
graphics (age, gender and education), the number of
children they have and ownership of eight household
assets.1 We estimated household wealth using the princi-
pal component analysis (PCA) method, with household
assets as a proxy for wealth (Filmer & Pritchett, 2001),
and we further classiﬁed wealth into quintiles. Table 1
further summarises all the covariates.
Ethical approvals were obtained from the College of
Medicine Research Ethics Committee in Malawi and
the Research Ethics Committee of the London School
of Hygiene and Tropical Medicine. We obtained written
informed consent from all participants in the extended
questionnaire before their interview.
Statistical methods
All analysis was undertaken in STATA version 14.0
(Stata Corporation, Texas, USA). Costs were estimated
in 2016 Malawi Kwacha (MWK) and converted to
2016 US dollars at an exchange rate of MWK 729.89/
US$ (Reserve Bank of Malawi, 2017).
Cost data were categorised into direct non-medical
costs and indirect costs. Direct non-medical costs
included those directly incurred by participants and
indirect costs refer to productivity and income losses
due to accessing testing services. We include data for
the entire sample who had complete cost data and pre-
sent it using means with 95% conﬁdence intervals. To
assess the burden imposed on participants, we compared
their total direct non-medical and indirect costs with the
national poverty line of US$1.20/day. The poverty line
was adopted from the Third Malawi Integrated House-
hold Survey (IHS) of 2011, converted to US$ at the aver-
age 2011 exchange rate of MWK162.84/US$ (National
Statistics Oﬃce, 2012; World Bank, 2018) and adjusted
for inﬂation using the national gross domestic product
(GDP) deﬂator for 2011 of 14% (World Bank, 2018).
To determine the signiﬁcant predictors of costs, we
estimated a multivariable two-part model (TPM). Indi-
vidual-level user cost data pose estimation challenges
since individual-level medical expenditures or costs of
treatment typically feature a spike at zero and are
strongly skewed with a heavy right-hand tail (Jones,
2010). There is no unique way to deal with these
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estimation challenges associated with cost data with lit-
erature recommending that the choice of appropriate
estimation approach should be determined by the
research questions and the characteristics of the data
(Buntin & Zaslavsky, 2004; Diehr, Yanez, Ash, Horn-
brook, & Lin, 1999; Gregori et al., 2011; Griswold, Parmi-
giani, Potosky, & Lipscomb, 2004). The common
proposed estimation approaches are the log-transformed
OLS, Tobit model, TPM and generalised linear models
(GLM) with a log-link function (Buntin & Zaslavsky,
2004; Gregori et al., 2011; Griswold et al., 2004; Jones,
2010; Nichols, 2010).
A Tobit regression model and a TPM were better ﬁt
for our data as they are both able to handle excess zer-
oes and positive distribution associated with cost data
(Jones, 2010). GLM and log-transformed ordinary
least squares (OLS) on the other hand, do not take
into account the excess zeroes in the data and therefore
generates biased estimates. We therefore, estimated a
log-transformed Tobit and a TPM with a logit model
for the ﬁrst part and log-transformed OLS regression
for the second part. Given our main objective, a TPM
is the appropriate estimation approach as it can dis-
tinguish the probability of incurring costs for testing
and assess signiﬁcant cost drivers for those who
incurred costs.
To account for the clustering of the data by district, a
ﬁxed eﬀect approach was used. We then applied a likeli-
hood ratio test to identify the most parsimonious model
between the restricted and unrestricted TPMmodels. We
further identiﬁed the most appropriate functional form
for age (testing for non-linearity) using the likelihood-
ratio test and did not ﬁnd signiﬁcant justiﬁcation for
this quadratic relationship.
We explored socio-demographic and socio-economic
variables and accessibility of testing centres as
Table 1. Descriptive statistics.
Variable Regression Inclusion Expected Direction
Gender Indicator:
Men (reference group)
Women
Men are expected to incur higher costs than women to reﬂect their higher
earning potential relative to women
Age (Years) Indicator:
16–19 Years; 20–24 Years; 25–39 Years; 40–64
Years; 65+ Years
Financial productivity is expected to increase with age starting from age 20 hence
raising the opportunity cost to testing up to age 65
Education Indicator:
No Formal education (reference group)
Incomplete Primary education
Some Secondary Education
Complete Secondary Education or higher
Education as a proxy for earning potential, implying that the higher the level of
education the higher the cost for testing
Number of Children Continuous: The participant’s number of
children
Number of children is positively associated with any child care costs a participant
might have incurred while accessing testing hence increasing the total costs
incurred
Test Location Indicator:
Facility-Based Testing (reference group)
Community HTC
Other Place
Community-based HTC reduces logistic barriers hence lowers the opportunity
cost of testing.
Other place testing depends on where the person tested for example, if at home
testing e.g., self-testing then lower costs than facility-based testing
Amount of Time Taken
to Receive Testing
Continuous: Time taken (including travel) in
hours to access HIV testing
The more time taken away from work to seek testing, the higher the cost of
testing through lost income
Reason for visiting
Testing Centre
Indicator:
Had other reasons for visiting a testing centre
aside from HIV testing (reference group)
Visited a testing centre speciﬁcally for an HIV
test
Visiting a testing centre for other reasons aside from HIV testing has potential of
economies of scope hence reduced total costs
Wealth Index Indicator:
Households are ranked into wealth quintiles
with the poorest as the reference group
Wealth is a proxy for ability to pay; the higher the wealth quintile, the higher the
participant’s expenditure to access testing
District of Residence Indicator:
Blantyre District (Reference Group)
Machinga District
Mwanza District
Neno District
There should not be diﬀerence in costs of testing by district
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determinants of total costs:
ln (Total Costsi + 1) = f
District, Gender,Wealthhh,Age categories, Education,Number of Children,
TimeTaken (Hours), Reason for visiting testing centre
[ ]
To reduce the skewness in the cost data, we modelled the
costs using a log transformation.We log transformed user
costs as ln (Total Costsi + 1) as suggested by the literature
(McCune,Grace, &Urban, 2002). Table 1 summarises the
a priori direction of association of the determinants.
Results
Participants’ characteristics
A total of 5551 participants were recruited into the base-
line survey and 1388 responded to the extended ques-
tionnaire. Seven hundred and forty-nine (14%)
participants reported having had at least one HIV test
in the previous 12 months, making them eligible for
this sub-study. Baseline characteristics of these 749 par-
ticipants are presented in Table 2. In brief, 32% of the
participants were men, 33% of the participants were
aged 16–24 years and 18% had no formal education.
Most of the participants (83%) reported facility-based
testing as their most recent testing approach. Among
those who tested in a facility, more participants (76%)
accessed testing through PITC. In addition, men
reported spending an average of 2.9 h and women
reported spending an average of 3.5 h to access testing
services.
Direct non-medical and indirect costs
Direct non-medical and indirect costs stratiﬁed by gen-
der and cost-category are summarised in Table 3.
Twenty percent of the participants incurred zero costs
for testing. The median cost for participants who
incurred costs was US$2.06. The mean total cost per par-
ticipant was US$2.45 (95%CI: US$2.11–US$2.70) with
lost income accounting for 83% of the total costs. Men
incurred higher mean total costs than women: US$3.81
(95%CI: US$2.91–US$4.50) versus US$1.83 (95%CI:
US$1.61–US$2.00).
Cost determinants
The logit component of the TPM demonstrated that
age, testing location, time taken to acquire a test, visit-
ing a facility speciﬁcally for an HIV test and district of
residence signiﬁcantly aﬀected the odds of incurring
costs for testing. The odds of incurring testing costs
are 18% higher for participants aged between 25–39
years than participants aged between 16–19 years. In
addition, participants who tested within their commu-
nities (mobile testing) had 61% lower odds of incurring
costs than participants who tested at facilities. Each
additional hour spent seeking testing increased the
odds of incurring costs by 48%. Participants who vis-
ited a testing site speciﬁcally for an HIV test had
48% higher odds of incurring costs for testing than
those who accessed testing in addition to other health
care services. And ﬁnally, residence in Mwanza district
was associated with 95% higher odds of incurring costs
when compared to residence in Blantyre district
(Tables 4 and 5).
Table 2. Participant characteristics (n = 749)a.
Men (n = 237,
32%)
Women (n = 512,
68%)
N Percentage N Percentage
Age (Years) 16–19 23 9.8% 52 10.2%
20–24 35 14.8% 135 26.4%
25–39 96 40.7% 205 40%
40–64 63 26.7% 102 19.9%
65+ 19 8.1% 18 3.5%
Education No formal Edu. 19 8.0% 112 21.9%
Primary Edu. 160 67.5% 331 64.7%
Some Secondary
Edu.
38 16.0% 57 11.1%
Complete
Secondary or
Higher Edu.
20 8.4% 12 2.3%
Wealth
Indexb,c
Lowest Quintile 64 27.0% 227 44.3%
2nd Lowest
Quintile
40 16.9% 57 11.1%
Middle Quintile 28 11.8% 69 13.5%
2nd Highest
Quintile
45 19.0% 70 13.7%
Highest Quintile 60 25.3% 89 17.4%
Test Location Hospital/Clinic/
Health Centre
148 62.5% 295 57.6%
ANC Clinic 17 7.2% 106 20.7%
VCT Centre 24 10.1% 31 6.1%
Community/
Mobile HTC
47 19.8% 74 14.5%
Other Testing
Place
1 0.42% 6 1.1%
Number of
Children
Mean (min-max) 3 (0–12) 3 (0–13)
Reason for
facility visit
HIV Test 168 70.9% 283 55.3%
HIV Test + Other
Services
69 29.1% 229 44.7%
Time Taken ≤1 h 73 30.8% 104 20.3%
1–3 h 83 35.0% 181 35.4%
3–6 h 66 27.9% 182 35.6%
>6 h 15 6.3% 45 8.8%
District Blantyre 62 26.2% 147 28.7%
Machinga 70 29.5% 172 33.6%
Mwanza 30 12.7% 51 10%
Neno 75 31.7% 142 27.7%
a3 Participants had incomplete data.
bWealth index estimated through undertaking principal component analysis
of responses to asset ownership and housing environment.
cAssets selected in the baseline data did not do well in diﬀerentiating the
poorest from one another.
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On the other hand, the log-transformed OLS com-
ponent of the TPM demonstrated that gender, age,
wealth, education and district of residence was associated
with signiﬁcant user costs. Holding everything else con-
stant, men on average incurred 52% higher costs for test-
ing than women.
Older age groups incurred signiﬁcantly higher costs
than the 16–19 age group. Participants aged between
20–24 years; 25–39 years incurred 61% and 96% higher
costs respectively, than participants aged between 16–
19 years. Participants aged between 40–64 years and
65+ years on average incurred more than double and
74% higher costs respectively, than participants aged
between 16–19 years. There was no diﬀerence in average
testing costs among participants with lower than com-
plete secondary education and those without any formal
education. However, participants with complete second-
ary education or higher on average incurred 63% higher
costs than those with no formal education. Finally, par-
ticipants in Mwanza district incurred on average 43%
higher costs than participants resident in Blantyre
district.
Table 3. Direct non-medical and indirect costs by gender and cost category.
Men (US$) Women (US$) Total Sample (US$)
Cost Category
Mean
(95% CI) % of Men
Mean
(95% CI)
% of
Women
Mean
95% CI % of Total Sample
Direct
non-medical costs
Transport 0.25
(0.15–0.36)
6.6% 0.16
(0.11–0.22)
8.7% 0.19
(0.14–0.24)
7.8%
Consultation 0.03
(0.00–0.05)
0.8% 0.03
(0.01–0.04)
1.6% 0.03
(0.01–0.04)
1.2%
Food 0.18
(0.14–0.22)
4.7% 0.13
(0.10–0.15)
7.1% 0.14
(0.12–0.17)
5.7%
Other 0.05
(0.02–0.09)
1.3% 0.02
(0.01–0.04)
1.1% 0.03
(0.02–0.05)
1.2%
Indirect
Costs
Child Care 0.06
(0.02–0.11)
1.6% 0.01
(0.00–0.03)
0.6% 0.03
(0.01–0.05)
1.2%
Lost Incomea 3.24
(2.45–4.03)
85.0% 1.48
(1.31–1.65)
80.9% 2.03
(1.75–2.31)
82.9%
Total direct non-medical and indirect
cost
3.81
(2.91–4.50)
100% 1.83
(1.61–2.00)
100% 2.45
(2.11–2.70)
100%
aLost Income had a median cost of US$1.37; US$2.06 for men and US$0.96 for women.
Table 4. Multivariable analysis of log-transformed Tobit regression model (Dependent Variable: total direct non-medical and indirect
costs).
Determinants (Reference Category) Coeﬃcient 95% CI P-value
Gender (Male)
Female −0.323*** (−)0.457–(−)0.189 0.000
Wealth (Lowest Quintile)
2nd Lowest Quintile −0.049 (−)0.239–0.141 0.613
Middle Quintile 0.169* (−)0.024–0.362 0.086
2nd Highest Quintile 0.003 (−)0.176–0.182 0.975
Highest Quintile 0.175** 0.007–0.343 0.041
Age (Years) (16–19)
20–24 0.411*** 0.178–0.643 0.001
25–39 0.640*** 0.406–0.873 0.000
40–64 0.685*** 0.395–0.974 0.000
65+ 0.195 (−)0.169–0.56 0.293
Education No Formal Edu.
Primary Edu. 0.013 (−)0.151–0.177 0.877
Incomplete Secondary Edu. 0.253** 0.017–0.489 0.036
Complete Secondary or Higher 0.530*** 0.198–0.863 0.002
Children No. of Children 0.000 (−)0.033–0.034 0.982
Testing Location Facility
Community −0.396*** (−)0.571–(−)0.220 0.000
Other −0.175 (−)0.858–0.508 0.614
Time Taken Time (Hours) 0.049*** 0.023–0.077 0.000
Reason for visiting HIV Test + Other
HIV Test 0.079 (−)0.045–0.204 0.211
District Blantyre
Machinga 0.059 (−)0.097–0.214 0.460
Mwanza 0.350*** 0.139–0.560 0.001
Neno −0.007 −0.164–0.149 0.927
Constant 0.208 (−)0.113–0.529 0.164
Observations 746a
Note: ***p < 0.01, **p < 0.05, *p < 0.1.
a3 observations had incomplete data.
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Discussion
This study examined the costs borne by users when
accessing HIV testing services in rural villages of
Southern Malawi. Our ﬁndings indicate that the average
cost of accessing HIV testing in rural Malawi is less than
that reported in urban areas of the country (US$3.09 per
test) (Maheswaran et al., 2016), yet rural testers incur
costs that are equivalent to twice the daily minimum
income required for their basic needs (national poverty
line at US$1.20 a day) (National Statistics Oﬃce, 2012).
In a country where at least 51% of the population live
below the national poverty line and 71% live below the
international poverty line of US$1.90 a day (National
Statistics Oﬃce, 2012; World Bank, 2014), these costs
are likely to be prohibitive for a large proportion of the
population.
Our study also demonstrated that there are signiﬁ-
cant average cost diﬀerences between men (US$3.81)
and women (US$1.83). Historically, there has been
low uptake of HIV testing and poor linkage into care
amongst men relative to women, particularly in sub-
Saharan Africa (Camlin et al., 2016). It is likely that
these high costs have contributed to the lower uptake.
Seeking testing imposes both a direct non-medical
cost but also the lost opportunity cost of hours away
from productive activities (Angotti et al., 2009; Ganesh,
2015; Musheke et al., 2013; Wolﬀ et al., 2005). Our
ﬁndings show that these opportunity costs comprise a
signiﬁcant proportion (83%) of the total testing costs
in this population. For most, the prospect of learning
their HIV status may not be a suﬃcient incentive to
bear these costs (Angotti et al., 2009), unless they are
already sick. This is further evidenced by the large pro-
portion of men in our sample who accessed testing
through PITC (70%) and very few who voluntarily
attended facilities for the sole purpose of learning
their HIV status (10%), suggesting that most men in
rural Malawi access testing as an add-on to other health
care services, rather than seeking out testing
independently.
The large proportion of total costs associated with lost
income was driven by long travel times and long waiting
times at testing facilities. On average, participants spent
three hours to access HIV testing services, with men
spending less time (2.9 h) than women (3.5 h). Similar
long wait times (3.4 h) were observed among adults uti-
lising public sector HIV and TB services in South Africa
(Chimbindi et al., 2015). Taking measures to improve
eﬃciency at HIV testing facilities, such as increasing
staﬃng for this service, could reduce waiting times and
therefore reduce the time taken from employment and
other activities.
Delivering HIV testing closer to people’s homes or at
times convenient to users may also mitigate ﬁnancial
barriers to testing. We found that community-based
testing is associated with a lower probability of incur-
ring costs than facility-based testing, therefore decentra-
lising testing services beyond static facilities may be
necessary to increase uptake. The popularity, especially
among men, of community-based HIV testing and
HIVST models has been previously demonstrated
(Angotti et al., 2009; Choko et al., 2015; Morin et al.,
2006; Mwenge et al., 2017; Sebapathy, Van den Bergh,
Fidler, Hayes, & Ford, 2012; Sharma et al., 2015;
World Health Organization, 2015). HIVST and other
home-based testing can be advantageous in that they
substantially reduce or completely eliminate costs
borne by users when testing (Maheswaran et al., 2016;
Sharma et al., 2015).
Financial and non-ﬁnancial incentives also oﬀer an
alternative to reducing or oﬀsetting testing costs and
Table 5. Multivariable analysis of Two-Part Model on total direct
non-medical and indirect costs with ﬁrst part (logit) and second
part (Log-transformed OLS).
Determinants (Reference Category)
Two-Part Model
logit
Log-transformed
OLS
Gender (Male)
Female −0.221 −0.517***
Wealth (Lowest Quintile)
2nd Lowest Quintile −0.196 −0.0113
Middle Quintile −0.108 0.398***
2nd Highest Quintile −0.168 0.0644
Highest Quintile 0.342 0.161
Age (Years) (16–19)
20–24 0.468 0.610***
25–39 0.777** 0.964***
40–64 0.674 1.031***
65+ −0.323 0.736***
Education (No Formal Edu.)
Primary Edu. 0.177 −0.0569
Incomplete
Secondary Edu.
0.430 0.248
Complete Secondary
Edu.
0.951 0.628***
Number of
Children
No. of Children 0.0604 −0.0164
Testing
Location
(Facility)
Community testing −0.946*** −0.204
Other −0.820 0.0617
Time Taken Time (Hours) 0.203*** 0.0161
(0.0530) (0.0197)
Reason for
visiting
(HIV Test + Other)
HIV Test 0.393* 0.0374
District (Blantyre)
Machinga 0.253 0.0857
Mwanza 0.666* 0.434***
Neno −0.190 0.0594
Constant −0.0902 −0.118
Observations 746a 746a
Pseudo R2 0.116
Adjusted R2 0.1579
Log Likelihood −335.04519 −847.03399
Note: ***p < 0.01, **p < 0.05, *p < 0.1.
a3 observations had incomplete data.
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promoting uptake. Small non-monetary incentives are
associated with signiﬁcantly increased community test-
ing and HIV case diagnosis (Sibanda, Tumushime,
et al., 2017). It is worth noting that although small
ﬁnancial incentives have been eﬀective in increasing
health care uptake (Choko et al., 2017; Mangenah,
Sibanda, et al., 2017; Pettifor, MacPhail, Nguyen, &
Rosenberg, 2012), diﬀerent amounts of incentives
have diﬀerent levels of eﬀectiveness. Incentives that
cover transport and opportunity costs are generally
associated with better testing and linkage to care than
incentives equivalent to transport reimbursement only
(Choko et al., 2017).
Study limitations and strengths
Our study used retrospective interviews to collect expen-
diture data for participants’ most recent HIV test. This
approach introduces potential for recall bias. We limited
this recall bias by recruiting participants with an HIV test
within a period of 12 months preceding the interview. In
addition, there is potential for downward bias of the test-
ing costs because individuals with prohibitively high
expected costs will not have tested. Our follow-up
research will explore more advanced statistical models
to reduce this downward bias.
Despite these limitations, our study adds valuable
information to the literature on access to HIV testing.
Unlike previous studies, we included lost income as a
cost to testing which enabled us to determine the full
economic burden of testing on users in a rural setting.
Conclusion
Though HIV testing services are “free” in Malawi,
users incur costs to access these services in rural
parts of the country that are double the national pov-
erty line. In these contexts, men incur higher costs to
access HIV testing services than women, with lost
income as the largest cost component. Increasing
uptake of testing services, especially for men, will likely
require bringing testing services closer to the commu-
nities, improving eﬃciency of facility-based testing and
potentially introducing ﬁnancial or non-ﬁnancial
incentives as a way to motivate uptake and oﬀset the
total costs associated with this portion of the HIV
cascade.
Note
1. Asset index: Electricity, radio, working television set,
mobile phone, landline telephone, refrigerator and bed
with mattress.
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